Free Trial

Artelo Biosciences (ARTL) Competitors

Artelo Biosciences logo
$12.24 -0.03 (-0.20%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ARTL vs. CLSD, MRSN, LVTX, KPTI, XLO, AKTX, MAAQ, SNYR, RANI, and DYAI

Should you be buying Artelo Biosciences stock or one of its competitors? The main competitors of Artelo Biosciences include Clearside Biomedical (CLSD), Mersana Therapeutics (MRSN), LAVA Therapeutics (LVTX), Karyopharm Therapeutics (KPTI), Xilio Therapeutics (XLO), Akari Therapeutics (AKTX), Mana Capital Acquisition (MAAQ), Synergy CHC (SNYR), Rani Therapeutics (RANI), and Dyadic International (DYAI). These companies are all part of the "pharmaceutical products" industry.

Artelo Biosciences vs. Its Competitors

Clearside Biomedical (NASDAQ:CLSD) and Artelo Biosciences (NASDAQ:ARTL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

Artelo Biosciences has a net margin of 0.00% compared to Clearside Biomedical's net margin of -818.57%. Clearside Biomedical's return on equity of 0.00% beat Artelo Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Clearside Biomedical-818.57% N/A -114.23%
Artelo Biosciences N/A -226.99%-164.61%

Artelo Biosciences has lower revenue, but higher earnings than Clearside Biomedical. Clearside Biomedical is trading at a lower price-to-earnings ratio than Artelo Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clearside Biomedical$1.66M22.33-$34.35M-$0.41-1.16
Artelo BiosciencesN/AN/A-$9.83M-$17.94-0.68

Clearside Biomedical has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Comparatively, Artelo Biosciences has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500.

In the previous week, Clearside Biomedical had 2 more articles in the media than Artelo Biosciences. MarketBeat recorded 3 mentions for Clearside Biomedical and 1 mentions for Artelo Biosciences. Artelo Biosciences' average media sentiment score of 1.87 beat Clearside Biomedical's score of 1.02 indicating that Artelo Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Clearside Biomedical Positive
Artelo Biosciences Very Positive

18.8% of Clearside Biomedical shares are held by institutional investors. Comparatively, 0.9% of Artelo Biosciences shares are held by institutional investors. 6.2% of Clearside Biomedical shares are held by company insiders. Comparatively, 0.8% of Artelo Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Clearside Biomedical presently has a consensus target price of $4.20, indicating a potential upside of 780.50%. Artelo Biosciences has a consensus target price of $25.00, indicating a potential upside of 104.16%. Given Clearside Biomedical's higher possible upside, analysts clearly believe Clearside Biomedical is more favorable than Artelo Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clearside Biomedical
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17
Artelo Biosciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
3 Strong Buy rating(s)
3.60

Summary

Clearside Biomedical beats Artelo Biosciences on 9 of the 16 factors compared between the two stocks.

Get Artelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARTL vs. The Competition

MetricArtelo BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.57M$3.06B$5.61B$9.56B
Dividend YieldN/A2.39%4.71%4.03%
P/E Ratio-0.6821.5127.9020.10
Price / SalesN/A205.32392.4667.55
Price / CashN/A42.5736.3258.75
Price / Book2.318.338.395.83
Net Income-$9.83M-$55.06M$3.25B$259.10M
7 Day Performance-16.93%-2.37%-1.61%-2.35%
1 Month Performance-7.72%15.92%9.08%9.75%
1 Year Performance50.06%5.53%35.49%17.02%

Artelo Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARTL
Artelo Biosciences
3.0107 of 5 stars
$12.25
-0.2%
$25.00
+104.2%
+57.3%$8.57MN/A-0.685
CLSD
Clearside Biomedical
2.4307 of 5 stars
$0.45
-10.5%
$4.20
+843.6%
-59.0%$38.64M$1.66M-1.0930Positive News
Gap Down
MRSN
Mersana Therapeutics
3.9317 of 5 stars
$6.83
-11.3%
$130.00
+1,803.4%
-86.3%$38.39M$40.50M-11.58150News Coverage
Stock Split
LVTX
LAVA Therapeutics
2.3557 of 5 stars
$1.52
+6.3%
$3.17
+108.3%
-27.2%$37.62M$11.98M-1.4660Positive News
Gap Up
High Trading Volume
KPTI
Karyopharm Therapeutics
3.759 of 5 stars
$4.37
+0.5%
$37.40
+755.8%
-73.3%$37.58M$145.24M-0.33380Upcoming Earnings
Gap Up
XLO
Xilio Therapeutics
2.7778 of 5 stars
$0.68
-2.1%
$4.00
+486.5%
-28.6%$36.08M$6.34M-0.8170News Coverage
AKTX
Akari Therapeutics
2.6142 of 5 stars
$1.14
+1.3%
$5.00
+340.5%
-74.3%$36.04MN/A0.009High Trading Volume
MAAQ
Mana Capital Acquisition
N/A$4.39
-4.2%
N/A-26.8%$35.65MN/A0.001
SNYR
Synergy CHC
3.8024 of 5 stars
$3.72
-1.8%
$10.00
+168.8%
N/A$34.85M$34.83M0.0040News Coverage
RANI
Rani Therapeutics
2.4817 of 5 stars
$0.55
+3.6%
$7.33
+1,231.2%
-81.7%$33.63M$1.03M-0.56110Positive News
Upcoming Earnings
Gap Down
DYAI
Dyadic International
3.2754 of 5 stars
$1.11
+0.9%
$6.00
+440.5%
-17.8%$33.10M$3.49M-5.557Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:ARTL) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners